"Hematologic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.
| Descriptor ID |
D019337
|
| MeSH Number(s) |
C04.588.448 C15.378.400
|
| Concept/Terms |
Hematologic Neoplasms- Hematologic Neoplasms
- Hematologic Malignancy
- Neoplasms, Hematologic
- Hematologic Neoplasm
- Neoplasm, Hematologic
- Hematological Neoplasms
- Hematological Neoplasm
- Neoplasm, Hematological
- Neoplasms, Hematological
- Malignancies, Hematologic
- Malignancy, Hematologic
- Hematologic Malignancies
- Hematological Malignancies
- Hematological Malignancy
- Malignancies, Hematological
- Malignancy, Hematological
Hematopoietic Neoplasms- Hematopoietic Neoplasms
- Neoplasms, Hematopoietic
- Hematopoietic Neoplasm
- Neoplasm, Hematopoietic
- Hematopoietic Malignancies
- Hematopoietic Malignancy
- Malignancies, Hematopoietic
- Malignancy, Hematopoietic
|
Below are MeSH descriptors whose meaning is more general than "Hematologic Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Hematologic Neoplasms".
This graph shows the total number of publications written about "Hematologic Neoplasms" by people in this website by year, and whether "Hematologic Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 |
| 1997 | 2 | 0 | 2 |
| 1998 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 2 | 3 |
| 2002 | 2 | 2 | 4 |
| 2003 | 2 | 1 | 3 |
| 2005 | 4 | 2 | 6 |
| 2006 | 2 | 1 | 3 |
| 2007 | 1 | 1 | 2 |
| 2008 | 4 | 2 | 6 |
| 2009 | 1 | 1 | 2 |
| 2010 | 4 | 5 | 9 |
| 2011 | 7 | 0 | 7 |
| 2012 | 5 | 2 | 7 |
| 2013 | 6 | 1 | 7 |
| 2014 | 6 | 0 | 6 |
| 2015 | 16 | 3 | 19 |
| 2016 | 9 | 6 | 15 |
| 2017 | 4 | 1 | 5 |
| 2018 | 7 | 2 | 9 |
| 2019 | 7 | 1 | 8 |
| 2020 | 7 | 3 | 10 |
| 2021 | 7 | 2 | 9 |
| 2022 | 10 | 0 | 10 |
| 2023 | 6 | 0 | 6 |
| 2024 | 9 | 2 | 11 |
| 2025 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hematologic Neoplasms" by people in Profiles.
-
Racial disparities in clonal hematopoiesis and their impact on hematologic malignancies. J Hematol Oncol. 2025 Oct 24; 18(1):88.
-
Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndrome. Br J Haematol. 2025 Apr; 206(4):1109-1120.
-
Cardiovascular Complications of Immune Effector Cell Therapies in Pediatric Hematological and Solid Tumors. Pediatr Blood Cancer. 2025 Apr; 72(4):e31557.
-
Invasive Candidiasis in Pediatric Hematologic Malignancy: Increased Risk of Dissemination With Candida tropicalis. Pediatr Infect Dis J. 2025 Jan 01; 44(1):58-63.
-
Update on Recommendations for Surveillance for Children with Predisposition to Hematopoietic Malignancy. Clin Cancer Res. 2024 Oct 01; 30(19):4286-4295.
-
Approved CAR-T therapies have reproducible efficacy and safety in clinical practice. Hum Vaccin Immunother. 2024 12 31; 20(1):2378543.
-
Time to optimize vaccination strategies in blood cancer patients. Br J Haematol. 2024 Aug; 205(2):406-408.
-
Revisiting intrathecal thiotepa: Efficacy and safety in secondary CNS malignancies. Med Oncol. 2024 Jun 17; 41(7):177.
-
Bispecific antibodies and autologous chimeric antigen receptor T?cell therapies for treatment of hematological malignancies. Mol Ther. 2024 Aug 07; 32(8):2444-2460.
-
COVID-19 infection in children, adolescents, and young adults with Down syndrome and hematologic malignancies. Pediatr Blood Cancer. 2024 Aug; 71(8):e31082.